Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine
| dc.contributor.author | Camkurt, Mehmet Akif | |
| dc.contributor.author | Gulpamuk, Gizem | |
| dc.contributor.author | Findikli, Ebru | |
| dc.contributor.author | Elve, Rengin | |
| dc.date.accessioned | 2020-03-26T19:34:58Z | |
| dc.date.available | 2020-03-26T19:34:58Z | |
| dc.date.issued | 2017 | |
| dc.department | Selçuk Üniversitesi | en_US |
| dc.description.abstract | Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine. In particular, we discuss the course of hyper and normoprolactinemic galactorrhea. We managed this side effect initially by dose reduction and further by switching to essitalopram. Physicians should be aware of endocrinologic side effects such as galactorrhea during the serotonin and noradrenaline reuptake inhibitor treatment. | en_US |
| dc.identifier.doi | 10.9758/cpn.2017.15.2.181 | en_US |
| dc.identifier.endpage | 183 | en_US |
| dc.identifier.issn | 1738-1088 | en_US |
| dc.identifier.issn | 2093-4327 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.pmid | 28449567 | en_US |
| dc.identifier.scopusquality | Q2 | en_US |
| dc.identifier.startpage | 181 | en_US |
| dc.identifier.uri | https://dx.doi.org/10.9758/cpn.2017.15.2.181 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12395/34982 | |
| dc.identifier.volume | 15 | en_US |
| dc.identifier.wos | WOS:000401531000012 | en_US |
| dc.identifier.wosquality | Q3 | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.indekslendigikaynak | Scopus | en_US |
| dc.indekslendigikaynak | PubMed | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | KOREAN COLL NEUROPSYCHOPHARMACOLOGY | en_US |
| dc.relation.ispartof | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.selcuk | 20240510_oaig | en_US |
| dc.subject | Venlafaxine hydrochloride | en_US |
| dc.subject | Galactorrhea | en_US |
| dc.subject | Prolactin | en_US |
| dc.subject | Depression | en_US |
| dc.subject | Therapeutics | en_US |
| dc.subject | Management | en_US |
| dc.title | Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine | en_US |
| dc.type | Editorial | en_US |
